Box Layout

HTML Layout
Backgroud Images
Backgroud Pattern
  • E-mail : info_medicalmarketing@jindunmedical.com
  • Phone : +86 21 64057580
  • Address : Shanghai China

Prasugrel, although good, is a difficult substitute for clopidogrel in elderly patients with coronary artery disease

  • 2022-10-09
  • JINDUN MEDICAL

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]- 5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2 (4h)-one is used as the intermediate of Prasugrel .

WEITERLESEN

Reducing GI damage and replacing aspirin with clopidogrel, what to look for

  • 2022-10-09
  • JINDUN MEDICAL

D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochloride is used as the intermediate of Clopidogrel .

WEITERLESEN

Newly approved diabetes treatment drugs on the market, no miracle drugs, beware of deception, you need to know

  • 2022-10-09
  • JINDUN MEDICAL

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile is used as the intermediate of Trelagliptin succinate .

WEITERLESEN

Oral hypoglycemic drug king "change of ownership", the birth of a new 2 billion varieties! Top 10 big reshuffle, Keren, Lep ...... heavy first generic attack

  • 2022-10-09
  • JINDUN MEDICAL

2-cyano-5-fluorine benzyl bromide is used as the intermediate of Trelagliptin succinate .

WEITERLESEN

Sodium 8 - (2-hydroxybenzamido) octanoate Salcaprozate Sodium Manufacturer

  • 2022-10-09
  • JINDUN MEDICAL

Sodium 8 - (2-hydroxybenzamido) octanoate, or SNAC for short, is a kind of absorption promoter of dicarbophosphate compounds, which is used to treat gastrointestinal diseases, espe

WEITERLESEN

2,6-Dichlorobenzaldehyde,CAS NO.83-38-5,export,manufacture ,supplier

  • 2022-10-09
  • JINDUN MEDICAL

2,6-dichlorobenzaldehyde is an important intermediate in the synthesis of benzoylurea insecticides. It is used to synthesize the next intermediate, 2,6-dichlorobenzaldehyde oxime,

WEITERLESEN

Dimethyl sulfoxide industry in China after 2021 driven by the dual factors of export and domestic demand rapid development

  • 2022-10-09
  • JINDUN MEDICAL

It can be used as organic solvent, reaction medium and organic synthesis intermediate.

WEITERLESEN

How far can anti-TB treatment with linezolid really go?

  • 2022-10-09
  • JINDUN MEDICAL

Linezolid is a new synthetic antibacterial drug of oxazolidinone developed and produced by Pharmacia&Upiohn Company (acquired by Pfizer) in the United States.

WEITERLESEN

Latest data on ibrutinib in combination with venetoclax for first-line treatment of chronic lymphocytic leukemia released

  • 2022-10-09
  • JINDUN MEDICAL

On June 10, 2021, the American Journal of Medicine published a non-randomized phase II trial to evaluate the efficacy and safety of ibrutinib in combination with venetoclax in the

WEITERLESEN

Clinical data and adverse effects of venetoclax combined with azacitidine in the treatment of myelodysplastic syndrome

  • 2022-10-09
  • JINDUN MEDICAL

Used to synthesize BTK, PI3K and JAK-2 inhibitors, as well as pharmaceutical intermediates.

WEITERLESEN